All Stories

  1. Structural characterization of antibiotic self-immunity tRNA synthetase in plant tumour biocontrol agent
  2. Discovery of Novel Oral Protein Synthesis Inhibitors of Mycobacterium tuberculosis That Target Leucyl-tRNA Synthetase
  3. Crystal structure of hte Cryptosporidium muris cytosolic leucyl-tRNA synthetase editing domain complex with a post-transfer editing analogue of norvaline (Nv2AA)
  4. Crystal structure of the Cryptosporidium muris cytosolic leucyl-tRNA synthetase editing domain (apo structure)
  5. Crystal structure of the Cryptosporidium muris cytosolic leucyl-tRNA synthetase editing domain complex with the adduct AMP-AN6426
  6. Crystal structure of the Cryptosporidium muris cytosolic leucyl-tRNA synthetase editing domain complex with a post-transfer editing analogue of isoeucine (Ile2AA)
  7. Novel approach to fight toxoplasma and cryptosporidium
  8. Crystal structure of the P.falciparum cytosolic leucyl-tRNA synthetase editing domain (space group P1) containing deletions of insertions 1 and 3
  9. Crystal structure of the P.knowlesi cytosolic leucyl-tRNA synthetase editing domain
  10. Crystal structure of the P.falciparum cytosolic leucyl-tRNA synthetase editing domain (space group P21)
  11. Crystal structure of the P.falciparum cytosolic leucyl-tRNA synthetase editing domain (space group P1)
  12. Antimalarial Benzoxaboroles Target Plasmodium falciparum Leucyl-tRNA Synthetase
  13. Aminoacetylation Reaction Catalyzed by Leucyl-tRNA Synthetase Operates via a Self-Assisted Mechanism Using a Conserved Residue and the Aminoacyl Substrate
  14. Crystal structure of the ternary complex of Agrobacterium radiobacter K84 agnB2 LeuRS-tRNA-LeuAMS
  15. Analysis of the Resistance Mechanism of a Benzoxaborole Inhibitor Reveals Insight into the Leucyl-tRNA Synthetase Editing Mechanism
  16. Crystal structure of the LeuRS editing domain of Candida albicans in complex with the adduct AN2690-AMP
  17. Crystal structure of the LeuRS editing domain of Candida albicans Mutant K510A
  18. Crystal structure of the LeuRS editing domain of Candida albicans Mutant K510A in complex with the adduct formed by AN2690-AMP
  19. Structure and dynamics of the MKK7–JNK signaling complex
  20. Crystal structure of the E.coli LeuRS-tRNA complex with the non- cognate isoleucyl adenylate analogue
  21. The physiological target for LeuRS translational quality control is norvaline
  22. Crystal structure of mouse mu‐crystallin complexed with NADPH and the T3 thyroid hormone
  23. Crystal structure of Mycoplasma mobile Leucyl-tRNA Synthetase with Leu-AMS in the active site
  24. Leucyl-tRNA synthetase editing domain functions as a molecular rheostat to control codon ambiguity in Mycoplasma pathogens
  25. Ternary complex of E. coli leucyl-tRNA synthetase, tRNA(leu) and toxic moiety from agrocin 84 (TM84) in aminoacylation-like conformation
  26. Plant tumour biocontrol agent employs a tRNA-dependent mechanism to inhibit leucyl-tRNA synthetase
  27. Discovery of a Novel Class of Boron-Based Antibacterials with Activity against Gram-Negative Bacteria
  28. Structure of extended Tudor domain TD3 from mouse TDRD1 in complex with MILI peptide containing dimethylarginine 45.
  29. Structure of extended Tudor domain TD3 from mouse TDRD1
  30. The multiple Tudor domain-containing protein TDRD1 is a molecular scaffold for mouse Piwi proteins and piRNA biogenesis factors
  31. A Role for Fkbp6 and the Chaperone Machinery in piRNA Amplification and Transposon Silencing
  32. Ternary complex of E. coli leucyl-tRNA synthetase, tRNA(leu) and leucyl-adenylate analogue in the aminoacylation conformation
  33. Ternary complex of E. coli leucyl-tRNA synthetase, tRNA(leu) and leucine in the editing conformation
  34. Ternary complex of E. coli leucyl-tRNA synthetase, tRNA(leu) and the benzoxaborole AN2679 in the editing conformation
  35. Ternary complex of E. coli leucyl-tRNA synthetase, tRNA(leu) and the benzoxaborole AN2679 in the editing conformation
  36. Structural dynamics of the aminoacylation and proofreading functional cycle of bacterial leucyl-tRNA synthetase
  37. Mutational and Metal Binding Analysis of the Endonuclease Domain of the Influenza Virus Polymerase PA Subunit
  38. Crystallization by capillary counter-diffusion and structure determination of the N114A mutant of the SH3 domain of Abl tyrosine kinase complexed with a high-affinity peptide ligand
  39. Crystallographic structure of human Tsg101 UEV domain
  40. Structure of human TSG101 UEV domain
  41. Thermodynamic Dissection of the Binding Energetics of Proline-rich Peptides to the Abl-SH3 Domain: Implications for Rational Ligand Design